title: Is the continued use of UK plasma sourced cryoprecipitate justified?
authors.affiliation: Department of Haematology, Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK. m.makris@sheffield.ac.uk.
authors.forename: Mike
authors.initials: M
authors.lastname: Makris
mesh_terms: D000347:Afibrinogenemia / Q000209:etiology* / Q000628:therapy*; D005169:Factor VIII / Q000627:therapeutic use*; D005340:Fibrinogen / Q000627:therapeutic use*; D006801:Humans
chemical_list: D005169:Factor VIII; D005340:Fibrinogen
keywords: cryoprecipitate; efficacy; fibrinogen; safety; variant Creutzfeldt-Jakob disease